S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
NASDAQ:AVIR

Atea Pharmaceuticals News Headlines

$7.29
+0.86 (+13.37%)
(As of 05/13/2022 06:55 PM ET)
Add
Compare
Today's Range
$6.47
$7.36
50-Day Range
$5.33
$7.33
52-Week Range
$5.31
$46.91
Volume
1.20 million shs
Average Volume
939,612 shs
Market Capitalization
$606.95 million
P/E Ratio
14.29
Dividend Yield
N/A
Beta
-0.58
Get Atea Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVIR and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Atea Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVIR
News Sentiment

0.07

0.48

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVIR Articles
This Week

19

1

AVIR Articles
Average Week



Atea Pharmaceuticals (NASDAQ:AVIR) News Headlines Today

SourceHeadline
marketbeat.com logoFY2022 EPS Estimates for Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Lowered by Analyst
marketbeat.com - May 13 at 9:47 AM
MarketBeat logoAtea Pharmaceuticals, Inc. (NASDAQ:AVIR) Forecasted to Earn Q2 2022 Earnings of ($0.52) Per Share
americanbankingnews.com - May 15 at 1:58 AM
MarketBeat logoSVB Leerink Equities Analysts Lower Earnings Estimates for Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
americanbankingnews.com - May 14 at 3:56 AM
MarketBeat logoAtea Pharmaceuticals (NASDAQ:AVIR) Trading 9% Higher After Better-Than-Expected Earnings
americanbankingnews.com - May 12 at 1:52 AM
finance.yahoo.com logoA Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) insider increased their holdings by 106% last year
finance.yahoo.com - May 11 at 11:33 AM
fool.com logoAtea Pharmaceuticals, Inc. (AVIR) Q1 2022 Earnings Call Transcript
fool.com - May 10 at 7:27 PM
seekingalpha.com logoAtea Pharmaceuticals, Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 5:57 PM
benzinga.com logoAtea Pharmaceuticals: Q1 Earnings Insights
benzinga.com - May 10 at 12:56 PM
seekingalpha.com logoAtea Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 10 at 10:23 AM
finance.yahoo.com logoAtea Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - May 10 at 7:47 AM
MarketBeat logoAtea Pharmaceuticals (AVIR) to Release Earnings on Tuesday
americanbankingnews.com - May 9 at 5:18 AM
finance.yahoo.com logoAtea Pharmaceuticals to Host First Quarter 2022 Financial Results Conference Call on May 10, 2022
finance.yahoo.com - May 3 at 5:51 PM
finance.yahoo.com logoWhat Kind Of Investors Own Most Of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)?
finance.yahoo.com - March 30 at 1:23 PM
finance.yahoo.com logoAtea Pharmaceuticals, Inc. (AVIR) Surges 7.4%: Is This an Indication of Further Gains?
finance.yahoo.com - March 21 at 11:54 AM
benzinga.com logoAtea Pharmaceuticals Earnings Perspective: Return On Invested Capital
benzinga.com - March 2 at 1:04 PM
morningstar.com logoThinking about buying stock in CTI BioPharma, 3D Systems, Atea Pharmaceuticals, Editas Medicine, or Mullen Automotive?
morningstar.com - March 1 at 5:00 PM
msn.com logoAtea Pharma stock jumps as earnings rise, potential COVID-19 therapy advances
msn.com - March 1 at 1:40 AM
fool.com logoAtea Pharmaceuticals, Inc. (AVIR) Q4 2021 Earnings Call Transcript
fool.com - February 28 at 11:16 PM
finance.yahoo.com logoAtea Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
finance.yahoo.com - February 28 at 8:40 PM
finance.yahoo.com logoAtea Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on February 28, 2022
finance.yahoo.com - February 22 at 7:16 PM
finance.yahoo.com logo8 Biotech Stocks So Cheap That Their Technology Is Effectively Free
finance.yahoo.com - February 16 at 2:19 PM
finance.yahoo.com logoCan Anyone Challenge Pfizer's Covid Dominance? Why These Biotechs Say Yes
finance.yahoo.com - February 11 at 10:09 AM
finance.yahoo.com logoAtea Pharmaceuticals Appoints Nancy Gail Berry Agrawal, Ph.D., as Executive Vice President of Preclinical Development
finance.yahoo.com - February 10 at 2:07 PM
finance.yahoo.com logoAtea Pharmaceuticals to Present at 11th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 9 at 9:58 AM
finance.yahoo.com logoAtea Pharmaceuticals Announces Publication of Data Supporting Bemnifosbuvir’s (AT-527) Novel Mechanism of Action Against SARS-CoV-2 in Nature Communications
finance.yahoo.com - February 2 at 8:13 AM
finance.yahoo.com logoWith A 4.3% Return On Equity, Is Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) A Quality Stock?
finance.yahoo.com - January 28 at 9:14 AM
morningstar.com logoAtea Pharmaceuticals Inc Ordinary Shares AVIR
morningstar.com - January 25 at 7:14 PM
nasdaq.com logoAtea Pharmaceuticals, Inc. Common Stock (AVIR)
nasdaq.com - January 25 at 7:14 PM
seekingalpha.com logoAtea Pharma highlights strategic priorities for 2022
seekingalpha.com - January 7 at 9:19 AM
finance.yahoo.com logoAtea Pharmaceuticals Highlights Strategic Priorities for 2022
finance.yahoo.com - January 7 at 9:19 AM
seekingalpha.com logoAtea cut to Underweight at Morgan Stanley citing concerns over oral COVID-19 drug
seekingalpha.com - January 6 at 6:00 PM
finance.yahoo.com logoAtea Pharmaceuticals to Present at 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 8:34 AM
finance.yahoo.com logoAtea Pharmaceuticals Added to the Nasdaq Biotechnology Index
finance.yahoo.com - December 17 at 8:59 AM
markets.businessinsider.com logoAfter Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
markets.businessinsider.com - December 15 at 8:27 AM
finance.yahoo.com logoAtea Pharmaceuticals Introduces New Strategic Clinical Development Program for AT-527 in COVID-19
finance.yahoo.com - December 14 at 8:09 PM
finance.yahoo.com logoHedge Funds Are Piling Into Atea Pharmaceuticals, Inc. (AVIR)
finance.yahoo.com - December 12 at 2:33 PM
finance.yahoo.com logoImplied Volatility Surging for Atea (AVIR) Stock Options
finance.yahoo.com - December 1 at 3:09 PM
finance.yahoo.com logoAtea Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
finance.yahoo.com - November 22 at 9:38 AM
markets.businessinsider.com logoWhat 5 Analyst Ratings Have To Say About Atea Pharmaceuticals
markets.businessinsider.com - November 18 at 3:15 PM
finance.yahoo.com logoAtea (AVIR) Plunges on Termination of Collaboration With Roche
finance.yahoo.com - November 17 at 1:13 PM
reuters.com logoAtea Pharma says deal to develop COVID-19 pill with Roche terminated
reuters.com - November 16 at 7:44 PM
finance.yahoo.com logoAtea Pharmaceuticals Provides Update on Strategic Collaboration with Roche
finance.yahoo.com - November 16 at 7:44 PM
finance.yahoo.com logoUPDATE 1-Roche terminates partnership with Atea to develop COVID-19 pill
finance.yahoo.com - November 16 at 7:44 PM
finance.yahoo.com logoAtea Pharma Stock Collapses As Roche Pulls The Plug On Pfizer-Rivaling Covid Pill
finance.yahoo.com - November 16 at 7:44 PM
finance.yahoo.com logoAtea Pharmaceuticals Inc (AVIR) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 12 at 9:34 AM
finance.yahoo.com logoAtea Pharmaceuticals Provides Clinical and Corporate Update and Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 11 at 7:15 PM
finance.yahoo.com logoIs There Any Hope for Atea Pharmaceuticals Stock?
finance.yahoo.com - November 4 at 8:52 AM
finance.yahoo.com logoAtea Pharmaceuticals to Host Third Quarter Financial Results Conference Call on November 11, 2021
finance.yahoo.com - November 4 at 8:52 AM
finance.yahoo.com logoInvestors one-year losses grow to 62% as the stock sheds US$90m this past week
finance.yahoo.com - October 30 at 1:54 PM
finance.yahoo.com logoWhy Atea Pharmaceuticals Stock Got Crushed This Week
finance.yahoo.com - October 22 at 7:56 PM
finance.yahoo.com logoJ.P. Morgan’s Bullish Stance on Atea Pharmaceuticals Stock Comes to an End
finance.yahoo.com - October 21 at 1:26 AM
Get Atea Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVIR and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.